2012
DOI: 10.1118/1.4735138
|View full text |Cite
|
Sign up to set email alerts
|

SU-E-T-81: Development and Implementation of a Remote Audit Tool for High Dose Rate (HDR) Ir-192 Brachytherapy Using Optically Stimulated Luminescence Dosimetry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Tedgren and Grindborg (2008) audited source strength using a well-chamber at 14 centres in Sweden. More recently, Casey et al (2012) has developed a remote audit tool in USA using optically stimulated luminescence dosimetry to measure dose at two points from a single straight catheter, and Haworth et al (2009Haworth et al ( , 2013 has completed a pilot audit in seven Australian centres using TLD to measure dose at a single point from six dwell positions uniformly distributed in three straight catheters. There is also a UK audit of well chamber consistency being conducted during 2012-13 by Lee et al 2013, Clatterbridge Cancer Centre (as yet unpublished) and there have been audits using TLD around clinical applicators conducted by the Midlands Audit Group in UK (unpublished).…”
Section: Introductionmentioning
confidence: 99%
“…Tedgren and Grindborg (2008) audited source strength using a well-chamber at 14 centres in Sweden. More recently, Casey et al (2012) has developed a remote audit tool in USA using optically stimulated luminescence dosimetry to measure dose at two points from a single straight catheter, and Haworth et al (2009Haworth et al ( , 2013 has completed a pilot audit in seven Australian centres using TLD to measure dose at a single point from six dwell positions uniformly distributed in three straight catheters. There is also a UK audit of well chamber consistency being conducted during 2012-13 by Lee et al 2013, Clatterbridge Cancer Centre (as yet unpublished) and there have been audits using TLD around clinical applicators conducted by the Midlands Audit Group in UK (unpublished).…”
Section: Introductionmentioning
confidence: 99%